Form 8-K - Current report:
SEC Accession No. 0001564590-22-006690
Filing Date
2022-02-24
Accepted
2022-02-24 16:06:14
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cris-8k_20220224.htm   iXBRL 8-K 42176
2 EX-99.1 d318642dex991.htm EX-99.1 140783
3 GRAPHIC g318642logo.jpg GRAPHIC 18124
  Complete submission text file 0001564590-22-006690.txt   353722

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cris-20220224.xsd EX-101.SCH 5681
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20220224_lab.xml EX-101.LAB 20183
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20220224_pre.xml EX-101.PRE 12028
8 EXTRACTED XBRL INSTANCE DOCUMENT cris-8k_20220224_htm.xml XML 3676
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 22670900
SIC: 2836 Biological Products, (No Diagnostic Substances)